// App-Quantinova.ai

4808 : Identification of a novel compound, MO2455, that induces poly(ADP-ribose) (PAR) accumulation and inhibits the growth of cancer cells in vitro and in vivo

Researchers

Presenter

  • Tatsu Shimoyama

Principal Investigators

  • Takeshi Sawada

  • Mari Akimoto

  • Yuka Sasaki

  • Hiroaki Fujimori

  • Yoshinobu Ishikawa

  • Tadashi Okawara

  • Tetsumi Irie

  • Takeji Takamura

  • Kenji Matsuno

  • Kengo Inoue

  • Mitsuko Masutani

  • Fumiaki Koizumi

Medical Centers

  • Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan

  • National Cancer Center Research Institute, Tokyo, Japan

  • University of Shizuoka, Shizuoka, Japan

  • Kumamoto Health Science University, Kumamoto, Japan

  • Kyoto University, Kyoto, Japan

  • Kanagawa Institute of Technology, Kanagawa, Japan

  • Kogakuin University, Tokyo, Japan

  • Fuji Pharma Valley, Shizuoka, Japan

  • Nagasaki University Hospital, Nagasaki, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • ribose

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved